U.S. market Closed. Opens in 11 hours 33 minutes

CMPX | Compass Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312020-03-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue1.89M1.90M1.62M2.40M2.12M2.12MN/A
Gross Profit-1.89M-1.90M-1.62M-2.40M-2.12M-2.12MN/A
Operating Expenses48.47M41.66M31.26M27.81M34.05M34.05M38.31M
Selling, General & Admin11.05M11.66M10.93M12.91M11.60M11.60M11.22M
Research & Development37.42M30.00M20.34M14.90M22.45M22.45M27.09M
Other Operating ExpensesN/AN/A50.62MN/AN/AN/AN/A
Operating Income-50.36M-41.66M-81.88M-27.81M-34.05M-34.05M-38.31M
Other Expenses / Income7.87M2.43M-299.00K-1.66M-601.00K-601.00K233.00K
Before Tax Income-42.49M-39.23M-82.18M-29.47M-34.65M-34.65M-38.18M
Income Tax ExpensesN/A-2.43M370.00K32.00K91.00K91.00K103.00K
Net Income-42.49M-36.80M-82.55M-29.50M-34.74M-34.74M-38.29M
Interest ExpensesN/A2.36M370.00K908.00K1.23M1.23M767.00K
Basic Shares Outstanding127.03M105.19M62.87M30.78M52.11M52.11M52.11M
Diluted Shares Outstanding127.03M105.19M62.87M30.78M52.11M52.11M52.11M
EBITDA-48.47M-37.39M-29.61M-25.32M-31.19M-31.19M-35.73M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-42.49M-36.87M-81.81M-28.56M-33.42M-33.42M-37.42M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312020-03-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙